Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

FLUDEOXYGLUCOSE F18

FLUDEOXYGLUCOSE F-18

Standard Dose
20-300mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FLUDEOXYGLUCOSE F18 is listed in Drugs@FDA under application 209341 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FLUDEOXYGLUCOSE F-18 Form and strength INJECTABLE;INTRAVENOUS - 20-300mCi/ML Sponsor UNIV SOUTHERN CA Submission history Latest submission status date: 2020-12-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUDEOXYGLUCOSE F18 is listed in Drugs@FDA under application 209341 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUDEOXYGLUCOSE F-18 Form and strength INJECTABLE;INTRAVENOUS - 20-300mCi/ML Sponsor UNIV SOUTHERN CA Submission history Latest submission status date: 2020-12-16 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.